Eylea (aflibercept, J0178) Reimbursement — ASP & Payment Limit Trend

What this means for buy-and-bill margin

At the Q3 2026 limit of $743.605 per 1 mg, the implied ASP is about $701.514 and the on-paper add-on is $42.091 per 1 mg. After the 2% sequester on Medicare’s 80% share, the effective add-on is roughly 4.3% of ASP — about $30.165 per 1 mgwhen the full allowable is collected. Whether that covers your carrying cost, waste, and denials depends on your acquisition price against ASP — which is exactly the number the payment limit can’t see, and the comparison the practice X-Ray runs with your actuals.

Billing essentials: dose → units → dollars

Dose math. Wet AMD: 2 mg intravitreal every 8 weeks after three monthly loading doses — 2 billing units per injection (1 mg/unit). At the Q3 2026 limit of $743.605 per 1 mg, a typical 2-unit dose carries a Medicare allowable of about $1,487.21 — Medicare pays ~$1,165.973 after the sequester, and ~$297.442 rides on coinsurance collection. Part B spent $3.15 billion on J0178 in 2023 across 339,144 beneficiaries (CMS Part B drug-spending data).

Administration. 67028 — intravitreal injection (CMS billing article A53387); append LT/RT per eye.

Waste modifiers. Single-dose container — JW (documented discard) / JZ (no waste) modifiers required since July 2023. Run your own numbers on the buy-and-bill calculator.

The coding & patient-cost side. This page covers the provider-margin story; for Eylea’s full billing reference — dosing conversions, modifiers, admin CPT detail, payer policies, and what the patient owes — see Eylea on CareCost Estimate, our billing-reference sister site.

Sourcing & payer-control status

Where J0178stands in the national payers’ published sourcing programs (the office-vs-hospital setting distinction most coverage misses):

• Not on the UHC, Aetna CBM, Anthem, or Cigna Pathwell sourcing lists as of their current published versions — retina buy-and-bill pressure runs through step-therapy (Avastin-first) policies instead.

State law is the other half: the white-bagging laws-by-state tracker — 11 states currently ban payer sourcing mandates outright.

FAQ

Which limits moved this quarter, across all drugs: the ASP-change leaderboard. How this data is built and verified: the Data Desk. Billing reference (dosing, modifiers, admin CPTs): CareCost Estimate’s drug library.